Next Article in Journal
Exploring Metabolic Adaptations to the Acidic Microenvironment of Osteosarcoma Cells Unveils Sphingosine 1-Phosphate as a Valuable Therapeutic Target
Next Article in Special Issue
Calcium Signaling in the Thyroid: Friend and Foe
Previous Article in Journal
IFN-γ and CD38 in Hyperprogressive Cancer Development
Article

The Prognostic Role of Postablative Non-Stimulated Thyroglobulin in Differentiated Thyroid Cancer

1
Ist Department of Medicine, Medical School, University of Pecs, 13 Ifjusag, H-7624 Pecs, Hungary
2
IInd Department of Medicine and Nephrological Center, Medical School, University of Pecs, 1 Pacsirta, H-7624 Pecs, Hungary
3
Szentagothai Research Centre, University of Pecs, 20 Ifjusag, H-7624 Pecs, Hungary
*
Author to whom correspondence should be addressed.
Cancers 2021, 13(2), 310; https://doi.org/10.3390/cancers13020310
Received: 11 December 2020 / Revised: 5 January 2021 / Accepted: 12 January 2021 / Published: 15 January 2021
In the management of patients with differentiated thyroid cancer, thyroglobulin (Tg) is used as a tumor marker to predict residual disease. After surgery, the presence or absence of persistent disease and the risk for recurrent disease should be assessed. Risk categories may be changed during the course of disease; the reclassification of patients influences the management of the disease and the intensity of follow-up. The diagnostic and prognostic roles of postoperative stimulated and one-year postablative non-stimulated Tg was evaluated. The individual lowest and highest non-stimulated Tg values during the entire follow-up were also assessed. Non-stimulated Tg values had excellent diagnostic accuracy in predicting structural disease, and the risk classification based on these was significantly more accurate regarding outcome than that based on the postoperative stimulated Tg. Analysis of the lowest and highest Tg values highlighted that a patient’s risk category can be revised based on a single Tg measurement.
Thyroglobulin (Tg) is the most important tumor marker in differentiated thyroid cancer (DTC). The aim of this study was to assess the diagnostic and prognostic roles of postoperative stimulated and postablative lowest, highest, and one-year non-stimulated Tg values obtained during the follow-up of patients with DTC. In this retrospective study, 222 radioiodine-treated, anti-thyroglobulin antibody (TgAb)-negative DTC patients having at least 9 months’ follow-up time were included (172 papillary and 50 follicular cancers; median age: 48 (from 15 to 91) years; female–male ratio: 158/64; median (quartiles) follow-up time: 54 (22–97) months). The 2015 American Thyroid Association guidelines were applied as criteria of the therapeutic response. Postoperative stimulated Tg values had significantly lower diagnostic accuracy than any of the non-stimulated postablative Tg values. One-year non-stimulated Tg had excellent prognostic value for structural disease: a cut-off value of 0.85 ng/mL had an 88.1% diagnostic accuracy. If the Tg value did not decrease below 0.75 ng/mL at any time during follow-up, the risk of residual disease was 25 times higher. The highest non-stimulated Tg during follow-up was the best predictor of residual disease (e.g., a Tg value exceeding 7.7 ng/mL indicated a 30-fold increase in risk). Non-stimulated Tg values measured during follow-up have excellent diagnostic accuracy to predict structural disease in DTC patients. The risk classification of a patient can safely be modified based on even a single Tg measurement. View Full-Text
Keywords: differentiated thyroid cancer; papillary thyroid cancer; follicular thyroid cancer; thyroglobulin; prognostic factor differentiated thyroid cancer; papillary thyroid cancer; follicular thyroid cancer; thyroglobulin; prognostic factor
Show Figures

Figure 1

MDPI and ACS Style

Szujo, S.; Bajnok, L.; Bodis, B.; Nagy, Z.; Nemes, O.; Rucz, K.; Mezosi, E. The Prognostic Role of Postablative Non-Stimulated Thyroglobulin in Differentiated Thyroid Cancer. Cancers 2021, 13, 310. https://doi.org/10.3390/cancers13020310

AMA Style

Szujo S, Bajnok L, Bodis B, Nagy Z, Nemes O, Rucz K, Mezosi E. The Prognostic Role of Postablative Non-Stimulated Thyroglobulin in Differentiated Thyroid Cancer. Cancers. 2021; 13(2):310. https://doi.org/10.3390/cancers13020310

Chicago/Turabian Style

Szujo, Szabina, Laszlo Bajnok, Beata Bodis, Zsuzsanna Nagy, Orsolya Nemes, Karoly Rucz, and Emese Mezosi. 2021. "The Prognostic Role of Postablative Non-Stimulated Thyroglobulin in Differentiated Thyroid Cancer" Cancers 13, no. 2: 310. https://doi.org/10.3390/cancers13020310

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop